Hematopoietic cell transplantation (HCT) is a procedure that can significantly influence the socioeconomic wellbeing of patients, caregivers and their families. Among 30 allogeneic HCT recipients and their caregivers enrolled on a pilot study evaluating the feasibility of studying financial impact of HCT, 16 agreed to participate in the long-term phase, completed a baseline questionnaire and received phone interviews at 6, 12, 18 and 24 months post HCT. Analyses showed that by 2 years post HCT, 54% of patients who previously contributed to household earnings had not returned to work and 80% of patients/caregivers reported transplant as having moderate to great impact on household income. However, patients' levels of confidence in their abilities to meet household financial obligations increased from baseline to 2 years. A relatively large proportion of patients reported inability to pay for medical care through this time period. Case studies demonstrated that patients' individual perceptions of the financial impact of HCT varies considerably, regardless of actual income. We demonstrate the feasibility of conducting a study to evaluate the financial impact of allogeneic HCT through 2 years post transplantation. Some patients/caregivers continue to experience a significant long-term financial burden after this procedure. Our study lays the foundation for a larger evaluation of patient/caregiver financial burden associated with HCT.
INTRODUCTION
Hematopoietic cell transplantation (HCT) has the potential to adversely affect the socioeconomic wellbeing of patients and their families. [1] [2] [3] [4] It is a highly specialized procedure that is available at select centers in the United States, such that patients and their caregivers frequently have to temporarily relocate to be close to a transplant center. Patients and caregivers often need to take an extended break from employment for pre-transplant treatments, transplantation and during the post-transplant recovery period. Routine household costs persist in this setting of lost wages and are compounded by direct and indirect health care-related costs such as insurance premiums, co-pays and deductibles, and costs associated with travel or relocation closer to a transplant center.
The financial impact of HCT on patients, families and caregivers has been inadequately studied. A few publications have reported out-of-pocket costs that are incurred by patients and their caregivers in the early post-transplant period. [5] [6] [7] [8] In a previous report, we have described patient and caregiver out-of-pocket costs, collected using patient and caregiver diaries, in the first 3 months after allogeneic HCT. 5 That article detailed costs collected from patient and caregiver diaries. The median out-ofpocket expenses during this time period were $2440, and patients and caregivers who required temporary lodging reported higher expenses compared with those who did not. The impact of HCT on long-term financial consequences is even less well known. Khera et al. 9 have recently reported a study where they surveyed allogeneic HCT recipients from a single center to evaluate the financial burden of transplantation. 9 In all, 73% of respondents indicated that their cancer had hurt them financially and 47% reported that they had experienced some form of financial burden, such as a decrease in household income by 450%, selling/mortgaging their home or withdrawing money from retirement savings.
This pilot study was conducted to evaluate the feasibility of prospectively capturing information from allogeneic HCT recipients and their families on out-of-pocket costs during the first 3 months and the long-term financial impact from 3 months to 2 years post transplantation. Results of the early post-transplant out-of-pocket costs phase, where patients maintained a cost diary, have been previously published. 5 This article reports the longterm follow-up and demonstrates the feasibility of collecting data on the financial impact of HCT over a 2-year time period. We also describe the changes in financial wellbeing that occurred in households of patients who participated in the study and present descriptive case studies to highlight the variety of financial experiences that HCT patients and their caregivers face during this time period.
MATERIALS AND METHODS Patients
Patient eligibility criteria and study design have been described previously. 2 Briefly, three transplant centers participated in this pilot study (Medical College of Wisconsin, Roswell Park Cancer Institute and University of Minnesota) and enrolled 10 patients each. Patients undergoing first allogeneic HCT with any diagnosis, any graft/donor source and any conditioning regimen were eligible provided they had a caregiver who was a member of the patient's household. As our study focused on financial issues specific to HCT, we restricted our eligibility criteria to patients who were within 2 years of diagnosis of their underlying disease. We also excluded patients who had previously received a transplant and patients from households where another family member had received a transplant. Patients had to be fluent in English to participate. The study was conducted under the guidance of Institutional Review Boards of the National Marrow Donor Program and the three participating transplant center sites. Both the patient and the caregiver provided informed consent before transplantation, and caregivers were given the option to continue on the study in the event of the patient's death.
Study design
Patients and caregivers participating in this study completed a 65-item baseline questionnaire pre-HCT that obtained comprehensive information on their household's finances. They subsequently completed and submitted a cost diary every 2 weeks to the study coordinating center at the Center for International Blood and Marrow Transplant Research (CIBMTR) through 3 months post transplantation. The results of the out-ofpocket phase portion of our pilot study have been reported previously. 5 A phone interview was conducted at 3 months post transplantation to obtain their feedback on the cost diary. At that time, they were also invited to continue on the long-term phase. Patients and caregivers who agreed to participate in the long-term phase received phone interviews at 6, 12, 18 and 24 months post HCT. Study participants received a $35 gift card for each interview completed. Data on patient and transplant characteristics were obtained from the CIBMTR database.
Interviews were conducted by phone by a research coordinator at the CIBMTR using a computer-assisted telephone interview script and lasted for 15-20 min each. Either the patient or the caregiver could complete the interview. After initial introductory questions, including an inquiry of patient status, the interviewer asked questions with structured options that the respondent could choose from. These included questions on their present location (home vs temporary relocation to closer to transplant center), household wage earners (number of earners and primary and secondary earner), total household income, any change in income since last interview, bankruptcy related to medical issues and financial accounts used to cover expenses.
Measurement of financial impact. Respondents were asked to use Likert scales to rate how the transplant had affected their household income (no impact to great impact) and their confidence in meeting their household's financial obligations (not at all confident to very confident). In addition, open ended questions asked patients/caregivers to describe how the transplant had affected their household financially, how the transplant will affect their household financially over the next 6 months and any other comments about their household financial situation. Responses were recorded and then transcribed for qualitative analyses.
The interviewer also asked the patient to complete the socioeconomic wellbeing scale. 10 This scale includes 17 items and was developed and validated to measure socioeconomic wellbeing in cancer patients.
Respondents were asked to rate their agreement with statements on a five-point Likert scale, reporting how true each statement had been for them within the preceding 7 days. Examples include 'I believe that being sick will hurt me financially', 'I am able to make enough money to pay for my health care', 'I am able to pay my medical bills', 'I have enough money to take care of my health-care needs', 'I can get the health insurance I need' and 'The medicine I need is too expensive for me'. Only patients were asked to complete this instrument. The scale was completed at baseline (pre-transplant) by all patients and by 12, 13, 12 and 10 patients at the 6, 12, 18 and 24 months follow-up, respectively.
Analysis
The primary aim of our study was to evaluate the feasibility of collecting information on long-term financial impact of allogeneic HCT and to pilot our data collection instruments. To establish feasibility, we specified a priori that 450% of patients/caregivers approached would continue on to the long-term follow-up phase of the study. Interviewers also monitored interviews to identify any questions that the patients/caregivers had difficulty in answering and also noted the number of attempts it took to schedule and conduct the phone interviews.
Descriptive statistics are reported for patient characteristics and patient and caregiver responses. Responses to open ended questions were analyzed using qualitative methods. Two trained coders independently analyzed and summarized responses using standard procedures. [11] [12] [13] Coders then met as a group to determine saturation of themes and any differences in opinion were discussed and resolved by consensus. The manuscript presents representative quotes to support key themes and to show the diversity of opinions reported by patients and caregivers.
To inform the design of a larger study, we also conducted a phone focus group of the study coordinators at the three sites to understand any barriers and challenges toward recruiting and enrolling patients on the financial impact study in general. Focus group discussion was analyzed using qualitative methods described above. Data are also presented on the number of attempts it took for interviewers to contact the patients and caregivers for conducting the phone interview.
RESULTS

Patients
Of the 30 patients enrolled pre-HCT, 25 completed the 3-month out-of-pocket diary phase of the study. From these patients, 16 patients/caregivers agreed to continue on the long-term phase. Table 1 describes the patient and transplant characteristics of the 16 study participants who are included in this analysis and the 9 patients/caregivers who were potentially eligible at the 3-month follow-up time point, but did not continue onto the long-term phase. Pre-transplant financial information for these patients is also shown. The groups (diary phase vs long-term phase) were comparable to the exception of household income and conditioning regimen intensity; myeloablative conditioning was used in a significantly larger proportion of patients enrolling on the long-term phase vs the diary phase. The household income of long-term phase participants was higher than patients who did not continue on the study (median annual household income was $80 400 vs $43 000). The number of patients enrolled on the long-term phase by site was nine from Roswell Park Cancer Institute, five from Medical College of Wisconsin and two from University of Minnesota.
Acute GVHD occurred in 10 (63%) patients (grade 1 in 3, grade 2 in 4 and grade 3 in 3 patients) and chronic GVHD was reported in 9 (56%) patients. During the 2 years of follow-up, 7 (44%) patients experienced disease relapse or progression. Four patients died during this time period (1 each between 3-6 month and 6-12 month interviews and 2 between 12-18 month interviews). However, caregivers for three of the deceased patients elected to continue on the study. The causes of death for these four patients were disease relapse (N = 3) or organ failure (N = 1).
Study feasibility, strategies for recruitment and challenges to enrollment
Overall, 53% (16/30) of all enrolled patients/caregivers and 64% (16/25) of potentially eligible patients/caregivers who had completed the 3-month diary phase continued on the long-term study phase. This met our a priori criterion for demonstrating the feasibility of conducting a study of the financial impact of allogeneic HCT till 2 years post transplantation. The majority of these 16 patients/caregivers completed the 2-year follow-up; interviews at 6, 12, 18 and 24 months were completed by 13 (81%), 15 (94%), 15 (94%) and 14 (88%) patients/caregivers, respectively.
To contact, schedule and conduct the interview, interviewers had to make a median of one phone contact at 6 months and two contacts at 12-, 18-and 24-month time points. Each interview required approximately 15 min to complete. On the basis of the interviewer assessment, patients/caregivers were able to answer questions without any problems. The phone survey asked about approximate household annual income (excluding any Social Security income), and patients/caregivers in general were willing to provide this information. This question was completed by 14/16 (88%) respondents at baseline, 12/16 (75%) at 6 months, 15/16 (94%) at 12 months, 14/16 (88%) at 18 months and 14/16 (88%) at 24 months.
Site coordinators at all three locations were the primary individuals who screened and consented patients/caregivers for the study. They suggested that the best time to approach and recruit patients was during pre-transplant work-up (range: 1 week-1 month pre-transplant) because: (1) recruiting participants during work-up gave patients ample time to review study documents, ask questions and feel comfortable with the study; (2) most patients were consented to other clinical studies during this same time; and (3) their caregiver was usually with them during work-up appointments. Engaging the caregiver was felt to be important for successful enrollment as the caregiver was most likely going to be responsible for keeping track of financial spending related to transplant. Other themes that were identified on focus group interviews to facilitate enrollment included availability of a dedicated study coordinator, having a physician champion for the study and obtaining buy in from other physicians at the transplant program. The reasons cited for patients withdrawing from the study were varied, and no specific theme was identified.
Patients stated 'not being interested in research' as the main reason for declining to participate in the study. Another reason was 'having good insurance coverage' and a perception that the transplant would not have any impact on their household finances. The study coordinators still encouraged patients with 'good coverage' to participate and felt that better educational materials about the study would facilitate overcoming this barrier to enrollment. Patients participating in this study were asked to participate in both the early diary phase and the long-term phone interview phase. Maintaining a daily cost diary deterred some patients/caregivers from participating in the study, as they felt journaling would take too much time. Some patients had questions about the privacy and confidentiality of the data that would be captured as part of this study. However, in the experience of the study coordinators, this was not a major deterrent to enrollment.
Financial impact of HCT through 2 years post transplant Although our main goal was to evaluate the feasibility of studying long-term financial impact of HCT, we describe below the household financial information obtained from our cohort of patients (N = 15). One patient/caregiver pair only completed one interview during follow-up and was excluded from this analysis (patient died during the long-term follow-up phase of the study and the caregiver completed the 12-month interview only). Notwithstanding the fact that pre-HCT therapies may influence household wage earner dynamics, the patient was the primary or secondary wage earner in 80% (12/15) of the households pretransplant (Figure 1) . At the 2-year follow-up, the patient was the primary or secondary wage earner in only 33% (5/15) households. After excluding patients who died, 5/11 patients (46%) had returned to work by 2 years post transplant. In most instances, the spouse or another household member was the primary wage earner for the household both pre-HCT and at the 2-year follow-up time period. HCT had a great impact on income and only somewhat confident in ability to meet Among the 15 patients/caregivers who participated in the longterm phase, 7 (54%) reported at least some reduction in pre-tax annual income ( Table 2 ). As can be expected, the household financial experience post transplant varied by social circumstances and availability of other financial resources. For example, in one household that experienced a decrease in income, the patient was able to return to work and remained the primary wage earner but the spouse was laid off from her job. In other households, a decrease in income was due to the patient or spouse/caregiver not being able to return to work. Still in other households, the caregiver was the primary wage earner and had to take time off from work to take care of patient. We highlight three case studies to demonstrate variation in perception of the financial impact of HCT, regardless of actual income (Table 3) .
HCT impact on socioeconomic well being Over time, the majority of patients continued to report that HCT had a significant impact on household income over time with 94% prevalence at baseline and 80% at 12 and 24 months ( Figure 2 ). However, patients' level of confidence in their ability to meet household financial obligations increased between baseline and 24 months. Most often, patients/caregivers had to rely on personal savings to pay transplant-related expenses with a small number using individual retirement arrangements (IRAs) and retirement savings as well. This is further detailed in Figure 3 , in which patients reported higher levels of agreement with statements focused on their ability to pay for medical care.
DISCUSSION
Financial burden may present as a major barrier to transplantation for some patients. 14 Patients who are able to receive HCT may struggle with the financial toxicity associated with long-term recovery and complications after transplantation. [1] [2] [3] [4] 9 With increasing awareness of the financial impact of cancer treatments, there is a critical need to understand the short-term and long-term economic burdens associated with HCT. Our study demonstrates that a significant proportion of patients continue to face financial challenges through at least 2 years post transplantation.
Although the sample size of our pilot study was small, our observations on the long-term financial burden faced by allogeneic HCT recipients and their caregivers contribute to our understanding in this area and will facilitate future studies.
A significant proportion of patients and their families continued to perceive HCT as having a major impact on household finances and reported 'financial toxicity' (as measured by the Socioeconomic Wellbeing Scale) until at least 2 years post transplantation. Interestingly, their reported confidence level in their ability to meet household financial obligations increased during this time period. This may represent patient/caregiver recognition and acceptance of the 'chronicity' of their recovery process and its associated financial uncertainty. From a methodological perspective, longitudinal studies investigating financial impact of HCT may need to incorporate approaches to account for a shift in response assessment. We also found that the financial experience of each household is very unique before and after transplantation and, anecdotally, may not correlate well with known sociodemographic factors. Qualitative research methods are an important component of investigating costs of transplantation from a patient perspective as they can summarize individual patient experiences. 2, 5 Return to work is an indicator of functional recovery for transplant survivors. In our study, only half of the patients who were working pre-HCT were able to return to work by 2 years post transplantation. Return to work post transplant is a complex personal decision for patients. In a qualitative literature review of cancer survivor work experiences, Stergiou-Kita et al. 15 identified return to work to be a continuous process with some key factors relevant to successful re-employment, including underlying symptoms, work abilities, coping, motivation, family support, work-place support, professional support, type of work/demands and job flexibility. Specifically for the HCT recipient population, Kirchhoff et al. 16 have proposed a similar model that considers cancer and treatment-related factors, pre-HCT demographic characteristics and physical functioning and mental health status during recovery. Other studies in autologous and allogeneic HCT recipients have reported return to work rates of up to 84% in 5-year survivors and rates comparable to their general population peers by 10 years post transplantation. [16] [17] [18] [19] Our study also shows the feasibility of conducting a phone interview based evaluation to capture data on the financial impact of allogeneic HCT through 2 years post transplantation. We highlight resources required, and identify challenges faced during recruitment and opportunities to enhance enrollment, to assist other investigators who may be planning studies in this area. Other designs to address patient household financial toxicity need to be explored in the context of HCT. These may include the use of secondary data (for example, claims data and tax records) so that patient burden for providing this information is minimized. Future designs also need to consider leveraging and integrating informatics and technology to optimize data collection and make patient reporting of financial toxicity more real time and efficient (for example, using smartphone-based patient-reported assessments).
Study limitations include a small sample size, which was appropriate for the pilot study objectives, and the potential for recall bias in patient/caregiver household income reporting. Also, the annual income of patients who participated in the long-term phase was higher compared with patients who completed the diary phase only and did not continue on the study. Only two patients from one site (University of Minnesota) continued on the long-term phase. This site was the first to get activated and informed study enrollment procedures, which in turn facilitated recruitment and retention of patients at the other two sites. Our findings may not be generalizable and reflect the experience of the small number of patients who were enrolled at the three sites, especially since our cohort did not include pediatric patients, racial/ethnic minorities and non-English speakers. However, our study was designed to be a pilot feasibility study that would inform a larger investigation of financial toxicity in HCT recipients. Despite these limitations, our study demonstrates the feasibility of collecting data over 2 years post transplant on household income, financial status and socioeconomic wellbeing from patients/caregivers, highlights important themes on financial burden patients/caregivers face post transplantation and lays the foundation for further research in the area of financial toxicity after HCT. While future studies in this area will increase our understanding about the predictors of and interventions to mitigate the adverse financial effects of HCT in vulnerable patients, our data highlight the immediate need for transplant centers to be aware of the profound negative impact HCT can incur on household finances for some patients. Social workers or psychosocial clinicians or related professionals can assist in identifying patients at high risk and can provide resources to patients and their caregivers for preventing and alleviating financial toxicity. Figure 3 . Agreement with select Socioeconomic Wellbeing Scale items on financial issues experienced by cancer patients.
